PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
CMG (350 mg tid) significantly lowered symptom scores compared to placebo [PMID:19961914].
Oral supplementation (2.8 g/day) significantly improved Inflammatory Bowel Disease Questionnaire (IBDQ) scores and decreased faecal lysozyme [PMID:30450689].
Total mastic (1 g/day) reduced total cholesterol by 11% over 8 weeks in healthy volunteers [PMID:26311707]. Chios Mastiha essential oil (200 mg/day) significantly improved triglycerides and LDL levels in adults with abdominal obesity [PMID:37329633].
Mastiha was not superior to placebo on changes in iron-corrected T1 and Liver Inflammation Fibrosis score in the entire population, though effects may vary by BMI [PMID:33629536].
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 32092498 (2020) — Traditional uses, phytochemistry and pharmacology of Chios mastic gum (Pistacia lentiscus var. Chia, Anacardiaceae): A review. · Journal of ethnopharmacology
- 2.PMID: 35276949 (2022) — Overview of Chios Mastic Gum (Pistacia lentiscus) Effects on Human Health. · Nutrients
- 3.PMID: 38892571 (2024) — Pistacia lentiscus: Phytochemistry and Antidiabetic Properties. · Nutrients
- 4.PMID: 39275256 (2024) — Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health. · Nutrients
- 5.PMID: 36437867 (2022) — Effects of Chios mastic gum on cardiometabolic risk factors. · World journal of diabetes